Patents Assigned to R.E.D. Laboratories, N.V./S.A.
  • Patent number: 7754707
    Abstract: Methods for treating a host suffering from a chronic immune disease, e.g., MS or CFS, are provided. In practicing the subject methods, an effective amount of an elastase inhibitory agent, e.g., a ?-lactam containing compound, is administered to the host. Also provided are compositions for use in practicing the subject methods.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: July 13, 2010
    Assignee: R.E.D. Laboratories, N.V./S.A.
    Inventors: Karim El Bakkouri, Patrick Englebienne, Kenny De Meirleir, Charles Vincent Herst
  • Patent number: 7527938
    Abstract: Methods are provided for diagnosing and/or characterizing chronic immune disease activity in a subject. In the subject methods, a sample is obtained from a subject suspected of having or known to have a chronic immune disease. The sample is then assayed for the presence of native Stat-1 protein and/or any lower molecular weight fragments of Stat-1 protein present. The assay results are used to diagnose the presence of chronic immune disease activity and/or characterize chronic immune disease activity in the subject, e.g., to confirm an initial chronic immune disease diagnosis, to determine the stage of the disease, to monitor disease progression, to predict disease attacks, and the like. In certain embodiments, the assay results are also used to predict the effectiveness of a particularly treatment protocol, e.g., to determine whether an interferon based treatment protocol will be effective. In addition, methods of Stat-1 based methods of treating chronic immune disease conditions are provided.
    Type: Grant
    Filed: June 17, 2002
    Date of Patent: May 5, 2009
    Assignee: R.E.D. Laboratories N.V./S.A.
    Inventors: Marc Fremont, Patrick Englebienne, C. V. Taylor Herst
  • Patent number: 6989239
    Abstract: Methods are provided for diagnosing/characterizing chronic immune disease activity in a subject. In the subject methods, a sample is obtained from a subject suspected of having or known to have a chronic immune disease. The sample is then assayed for the presence and amount of intact (i.e., native) p53 protein and/or fragments thereof. The assay results are used to diagnose the presence of chronic immune disease and/or characterize chronic immune disease activity in a subject, and/or to determine appropriate treatments protocols. Also provided by the subject invention are methods of treating chronic immune disease conditions by enhancing p53 activity. Also provided by the subject invention are kits for practicing the methods.
    Type: Grant
    Filed: June 17, 2002
    Date of Patent: January 24, 2006
    Assignee: R.E.D. Laboratories, N.V./S.A.
    Inventors: Marc Fremont, Patrick Englebienne, C. V. Taylor Herst